Dermapharm Holding SE's total assets for Q2 2026 were €2.24B, a decrease of -1.33% from the previous quarter. CH:DMP total liabilities were €1.71B for the fiscal quarter, a 11.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.